ImmunoPrecise Antibodies Ltd (IPA)
0.4445
-0.02
(-3.35%)
USD |
NASDAQ |
Nov 15, 16:00
0.43
-0.01
(-3.26%)
After-Hours: 20:00
ImmunoPrecise Antibodies Free Cash Flow (Quarterly): -1.524M for July 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | -1.524M |
| April 30, 2024 | -2.792M |
| January 31, 2024 | -0.3767M |
| October 31, 2023 | -0.4941M |
| July 31, 2023 | -0.5159M |
| April 30, 2023 | -2.223M |
| January 31, 2023 | -2.665M |
| October 31, 2022 | -3.074M |
| July 31, 2022 | -8.077M |
| April 30, 2022 | -1.61M |
| January 31, 2022 | -4.573M |
| October 31, 2021 | -1.664M |
| July 31, 2021 | -1.062M |
| April 30, 2021 | -0.7806M |
| January 31, 2021 | -0.8455M |
| October 31, 2020 | -0.1977M |
| July 31, 2020 | 0.2749M |
| April 30, 2020 | 0.3445M |
| January 31, 2020 | -0.2511M |
| October 31, 2019 | -1.322M |
| July 31, 2019 | -0.2447M |
| April 30, 2019 | -0.7685M |
| January 31, 2019 | -0.5237M |
| October 31, 2018 | -1.489M |
| July 31, 2018 | -0.1412M |
| Date | Value |
|---|---|
| April 30, 2018 | -0.6848M |
| January 31, 2018 | -0.4104M |
| October 31, 2017 | -0.8162M |
| July 31, 2017 | -1.037M |
| April 30, 2017 | |
| January 31, 2017 | |
| September 30, 2016 | -0.0166M |
| June 30, 2016 | 0.0007M |
| March 31, 2016 | -0.0004M |
| December 31, 2015 | -0.0004M |
| September 30, 2015 | -0.0016M |
| June 30, 2015 | 0.0018M |
| March 31, 2015 | -0.0027M |
| December 31, 2014 | 0.0431M |
| September 30, 2014 | -0.0478M |
| June 30, 2014 | 0.0039M |
| March 31, 2014 | -0.0319M |
| December 31, 2013 | -0.2533M |
| September 30, 2013 | 0.1801M |
| June 30, 2013 | 0.0066M |
| March 31, 2013 | -0.0515M |
| December 31, 2012 | 0.0041M |
| September 30, 2012 | -0.0117M |
| June 30, 2012 | 0.0065M |
| March 31, 2012 | -0.0032M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-8.077M
Minimum
Jul 2022
0.3445M
Maximum
Apr 2020
-1.690M
Average
-1.062M
Median
Jul 2021
Free Cash Flow (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 16.90M |
| Edesa Biotech Inc | -0.8565M |
| Lexaria Bioscience Corp | -1.288M |
| Xenon Pharmaceuticals Inc | -34.19M |
| ESSA Pharma Inc | -5.745M |